rimantadine has been researched along with Anasarca in 1 studies
Rimantadine: An RNA synthesis inhibitor that is used as an antiviral agent in the prophylaxis and treatment of influenza.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We report our experience with 7 consecutive patients with Parkinson's disease (PD) who received rimantadine (the alpha-methyl derivative of amantadine) in substitution of amantadine due to peripheral side effects (lower limb edema, livedo reticularis)." | 5.11 | Rimantadine in Parkinson's disease patients experiencing peripheral adverse effects from amantadine: report of a case series. ( Gonzalez, MA; Lieberman, A; Papapetropoulos, S; Roberts, EL; Singer, C, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Singer, C | 1 |
| Papapetropoulos, S | 1 |
| Gonzalez, MA | 1 |
| Roberts, EL | 1 |
| Lieberman, A | 1 |
1 trial available for rimantadine and Anasarca
| Article | Year |
|---|---|
Rimantadine in Parkinson's disease patients experiencing peripheral adverse effects from amantadine: report of a case series.
Topics: Aged; Amantadine; Antiparkinson Agents; Edema; Female; Humans; Middle Aged; Motor Activity; Parkinso | 2005 |